Colleen W Marano
机构:Johnson & Johnson (United States) · ORCID:0000-0002-4965-5142
发表论文 173 篇 · 总被引 8066 次 · h-index 35
代表论文
- Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies (2020 · Inflammatory Bowel Diseases · 被引 118)
- Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension (2022 · Journal of Crohn s and Colitis · 被引 103)
- Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis (2020 · Gastroenterology · 被引 82)
- Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments (2020 · Gut · 被引 73)
- Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy (2020 · Alimentary Pharmacology & Therapeutics · 被引 67)
- Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn’s Disease and 4 Years in Ulcerative Colitis (2024 · Journal of Crohn s and Colitis · 被引 46)